A biomarker helps select the patients who respond best to patritumab deruxtecan in breast cancer
A study promoted by SOLTI and published in Nature Communications describes the tumour biology associated with the activity of the drug patritumab der1
A study promoted by SOLTI and published in Nature Communications describes the tumour biology associated with the activity of the drug patritumab der1
In October, the association organized an activity to raise funds for breast cancer research at IDIBAPS.
“Female talent, scientists speak” is an IDIBAPS campaign that seeks to give visibility to female researchers and to reflect on the obstacles they fac1
As part of the International Day of Women and Girls in Science 2023, groups of between three and four secondary school students interested in biomedi1
On the occasion of World Cancer Day, to be held next Saturday, February 4, IDIBAPS, together with the AECC, has organized three meetings between volu1
On Thursday, 11 November, the Spanish Cancer Association (AECC) awarded the AECC 2021 Grants for Cancer Research at an event held at the organization1
In a study published in the Journal of Clinical Oncology, researchers from the Hospital Clínic-IDIBAPS-UB and SOLTI showed the predictive capacity of1